Risk factors for financial toxicity in patients with gynecologic cancer

Autor: Emeline M. Aviki, Beryl L. Manning-Geist, Stefania S. Sokolowski, Tiffanny Newman, Victoria S. Blinder, Fumiko Chino, Stephanie M. Doyle, Allison Liebhaber, Sushmita B. Gordhandas, Carol L. Brown, Vance Broach, Dennis S. Chi, Elizabeth L. Jewell, Mario M. Leitao, Kara Long Roche, Jennifer J. Mueller, Yukio Sonoda, Oliver Zivanovic, Ginger J. Gardner, Nadeem R. Abu-Rustum

Publikováno v: Am J Obstet Gynecol

The cost of cancer care is high and rising. Evidence of increased patient cost burden is prevalent in the medical literature and has been defined as "financial toxicity," the financial hardship and financial concerns experienced by patients because o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdda61a179feec323e105bc219b2212e
https://doi.org/10.1016/j.ajog.2021.12.012

Financial Toxicity Order Set: Implementing a Simple Intervention to Better Connect Patients With Resources.

Autor: Thom B; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Sokolowski S; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Abu-Rustum NR; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of OB/GYN, Weill Cornell Medical College, New York, NY., Allen-Dicker J; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Caramore A; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY., Chino F; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Doyle S; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Patient Financial Services, Memorial Sloan Kettering Cancer Center, New York, NY., Fitzpatrick C; Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY., Gany F; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY., Liebhaber A; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Newman T; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Rao N; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tappen J; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Social Work, Memorial Sloan Kettering Cancer Center, New York, NY., Aviki EM; Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY.; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 662-668. Date of Electronic Publication: 2023 Jun 15.

Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy.

Autor: Daly B; Memorial Sloan Kettering Cancer Center, New York, New York., Nicholas K; Memorial Sloan Kettering Cancer Center, New York, New York., Flynn J; Memorial Sloan Kettering Cancer Center, New York, New York., Silva N; Memorial Sloan Kettering Cancer Center, New York, New York., Panageas K; Memorial Sloan Kettering Cancer Center, New York, New York., Mao JJ; Memorial Sloan Kettering Cancer Center, New York, New York., Gazit L; Memorial Sloan Kettering Cancer Center, New York, New York., Gorenshteyn D; Memorial Sloan Kettering Cancer Center, New York, New York., Sokolowski S; Memorial Sloan Kettering Cancer Center, New York, New York., Newman T; Memorial Sloan Kettering Cancer Center, New York, New York., Perry C; Memorial Sloan Kettering Cancer Center, New York, New York., Wagner I; Memorial Sloan Kettering Cancer Center, New York, New York., Zervoudakis A; Memorial Sloan Kettering Cancer Center, New York, New York., Salvaggio R; Memorial Sloan Kettering Cancer Center, New York, New York., Holland J; Memorial Sloan Kettering Cancer Center, New York, New York., Chiu YO; Memorial Sloan Kettering Cancer Center, New York, New York., Kuperman GJ; Memorial Sloan Kettering Cancer Center, New York, New York., Simon BA; Memorial Sloan Kettering Cancer Center, New York, New York., Reidy-Lagunes DL; Memorial Sloan Kettering Cancer Center, New York, New York., Perchick W; Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: JAMA network open [JAMA Netw Open] 2022 Mar 01; Vol. 5 (3), pp. e221078. Date of Electronic Publication: 2022 Mar 01.

Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment.

Autor: Daly B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Gorenshteyn D; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Nicholas KJ; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Zervoudakis A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Sokolowski S; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Perry CE; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Gazit L; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Baldwin Medsker A; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY., Salvaggio R; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY., Adams L; Department of Advanced Practice Providers, Memorial Sloan Kettering Cancer Center, New York, NY., Xiao H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chiu YO; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Katzen LL; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Rozenshteyn M; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Reidy-Lagunes DL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Simon BA; Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY., Perchick W; Office of the Executive Vice President, Memorial Sloan Kettering Cancer Center, New York, NY., Wagner I; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2020 Mar; Vol. 4, pp. 275-289.

US healthcare costs attributable to type A and type B influenza.

Autor: Yan S; a GSK , Philadelphia , PA , USA., Weycker D; b Policy Analysis Inc. (PAI) , Brookline , MA , USA., Sokolowski S; b Policy Analysis Inc. (PAI) , Brookline , MA , USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2017 Sep 02; Vol. 13 (9), pp. 2041-2047.